Guardant Health, Inc.
Guardant Health, Inc. (GH) — Form 144: Proposed sale of shares
AI-generated summary
Director Azar Alex M II proposed to sell 207 shares of Guardant Health, Inc. common stock with an aggregate market value of $30,959 through Charles Schwab & Co., Inc. The shares were acquired via restricted stock lapse on November 12, 2026. The proposed sale is associated with a trading plan adopted on May 21, 2026.
Key facts
- Seller
- Azar Alex M II
- Relationship
- Director
- Shares to sell
- 207
- Market value
- $30,959.00
- Approximate sale date
- Nov 16, 2026
- Broker
- Charles Schwab & Co., Inc.
- Acquired
- Nov 12, 2026 · Restricted Stock Lapse - See Remarks
Rule 10b5-1 plan · adopted May 21, 2026
Remarks
- Shares on this filing may be sold and acquired over various dates.
More GH filings
- 4
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 144
Filed Nov 18, 2026
- 4
Filed Nov 17, 2026
- 4
Filed Nov 17, 2026
- 144
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.